Cipla | CIPLA - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Arca Biopharma USD 49.52M 2.58M 2026-03
aTyr Pharma USD 10.01M 735K 2026-03
Bio Path 13.65M 3.37M 2022-09
Brainstorm Cell Therapeutics USD 15K 14K 2026-03
Capricor Therapeutics USD 105.42M 182.42M 2026-03
Cara Therapeutics USD 20.73M 684K 2025-12
Cipla INR 7.96B 39.9M 2025-09
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Esperion Therapeutics USD 156.16M 11.69M 2026-03
Immunic USD 186.63M 171.15M 2026-03
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
TherapeuticsMD 523K 89K 2024-06
UPL INR 41.52B 53.85B 2025-09